Skip to main content
. 2014 May 16;9(5):e97928. doi: 10.1371/journal.pone.0097928

Table 1. Demographics of subjects with or without albuminuria and diabetic retiopathy.

Absence of albuminuria or retinopathy (n = 2500) Isolated albuminuria (n = 610) Isolated retinopathy (n = 86) Concomitance of albuminuria and wih retinopathy (n = 44)
Age (years) 60.2±11 62.4±11.2 64.5±9.8* 63.2±9.7
Male 1016(40.6) 160(26.2) 40(46.5) 13(29.5)
Systolic BP (mmHg) 129.4±18.2 134±19.1 138.7±20.5** 134.0±16.4
Diastolic BP (mmHg) 80.8±9.8 82.9±9.9 84.1±10.2* 81.4±9.7
BMI (kg/m2) 24.4±3.3 24.7±3.3 25.1±3.7 24.9±2.9
Waist circumference (cm) 82.1±9.5 83.3±9.4 85.6±10.7* 84.0±9.3
WHR 0.87±0.07 0.87±0.06 0.89±0.06* 0.88±0.06
FPG (mmol/L) 5.96±1.52 6.06±1.78 7.42±2.88* 8.79±3.91*
2hPG (mmol/L) 7.58±3.4.0 7.66±3.48 9.41±5.23* 10.54±7.78*
HbA1c (%) 5.7(5.4–6.1) 5.8(5.4–6.2) 6.5(5.8–7.7)* 7.4(6.0–10.3)*
Total cholesterol(mmol/L) 4.85±1.02 5.03±1.05 4.71±0.82 5.04±0.89
Triglyceride (mmol/L) 1.34(0.97–1.91) 1.40(1.00–2.04) 1.31(1.04–1.86) 1.38(0.97–2.15)
HDL-cholesterol (mmol/L) 1.33±0.37 1.33±0.37 1.25±0.33 1.31±0.40
LDL-c (mmol/L) 2.92±0.97 3.02±0.88 2.83±0.67 3.06±0.80
CRP 0.89(0.43–1.86) 1.43(0.73–3.21)* 0.67(0.40–2.01) 2.32(0.70–4.37)*
CVD 321(12.8) 112(18.4) 14(16.3) 11(25)
Current smoker 427(17.3) 63(10.3) 7(8.1) 7(15.9)
Hypertension 1260(50.4) 373(61.1) 64(74.4) 28(63.6)
Obesity 115(4.6) 35(5.7) 9(10.5) 1(2.3)
Diabetes 558(22.3) 161(26.4) 46(53.5) 28(63.6)
  Known 295(11.8) 93(15.2) 33(38.4) 24(54.5)
  Newly-diagnosed 263(10.5) 68(11.1) 13(15.1) 4(9.0)
IGR 696(27.8) 145(23.8) 17(19.8) 5(11.4)
Urine test 1439(57.6) 217(35.6) 58(67.4) 27(61.4)
 WBC positive 251(17.4) 42(19.4) 8(13.8) 3(11.1)
Metabolic syndrome
 IDF 781(31.5) 230(38.4) 38(44.2) 21(48.8)
 ATP III 1069(43.3) 298(50.4) 49(57) 26(61.9)
 CDS 761(30.6) 223(37.0) 41(47.7) 21(48.8)

Categorical variables were expressed as numbers (percentage).

Continuous variables were expressed as mean ± standard deviation or median (25% and 75%quartile) for non-normally distributed variables.

BMI, body mass index; BP, blood pressure; CVD,cardiovascular disease; FPG, fasting plasma glucose; 2hPG, 2-hour postprandial plasma glucose; HbA1c, glycated hemoglobin A1c; HDL, high density lipoprotein; LDL, low density lipoprotein.

*P<0.05,

**P<0.01 comparison with subgroup of absence of albuminuria or retinopathy using an one-way ANOVA with SNK analysis in regard to quantitative data and a Kruskal-Wallis H for non-normally distributed data.